GENOVA’s NOMOCa-AI Chat Clinches Three Major Awards in Market Research

GENOVA's NOMOCa-AI Chat Achieves Triple Win in Market Research

GENOVA, headquartered in Shibuya, Tokyo, and led by President Tomoki Hirase, proudly announces that its interactive AI chat service, NOMOCa-AI chat, has achieved remarkable success in a market research conducted by the Future Trend Research Institute. The service was recognized with three No.1 awards specifically within the clinic sector for chatbots, highlighting its extensive impact and efficiency.

Overview of Achievements

The NOMOCa-AI chat secured first place in the following categories:

1. Total number of installations (in the clinic sector)
2. Cumulative installations in the last year (in the clinic sector)
3. Revenue from the last year (in the clinic sector)

This recognition is a testament to the importance of efficiency and enhanced patient convenience in clinics nationwide, particularly in light of the human resource shortages that many clinics face.

Research Details

- Research Name: Market Research on Chatbots for the Clinic Sector
- Conducting Organization: Future Trend Research Institute
- Research Period: October 22 - October 27, 2025
- Method: Survey
- Target: Companies providing AI chatbots for the clinic sector

Reasons Behind Triple Recognition

NOMOCa-AI chat is an advanced AI solution that integrates the latest GPT-5 technology with specific knowledge acquired through the NOMOCa series tailored for clinics. Unlike traditional generic chatbots, NOMOCa-AI chat is specifically designed to provide accurate 24/7 automated responses to complex inquiries regarding FAQs and appointments in clinics.

The development and support structure that caters to the specific needs of the clinic environment have led to the NOMOCa-AI chat achieving the highest market shares in the three aforementioned categories.

Achieving Medical DX with NOMOCa-AI Chat

NOMOCa-AI chat significantly reduces the telephone answering burden on clinic reception staff, thereby relieving patient stress associated with waiting times.

Benefits for Staff:

- Reduced phone answering time allows staff to focus on their core responsibilities and patient interactions, contributing to alleviating human resource shortages and reducing overtime.

Benefits for Patients:

- Patients can effortlessly inquire or pre-book appointments 24/7 via LINE or the web outside of consultation hours, preventing loss of visit opportunities and enhancing overall convenience.

For more information, visit the detailed site for NOMOCa-AI chat.

Future Prospects

Inspired by this triple recognition, GENOVA is committed to further enhancing the functionalities and support systems of NOMOCa-AI chat. Additionally, we plan to strengthen our integration with medical reservation systems like SMARTOne, providing a comprehensive DX solution from reservations to billing, ultimately contributing to sustainable healthcare management.

About GENOVA

Established with the mission of "Connecting People and Healthcare to Create a Healthy Society," GENOVA offers innovative healthcare technology services. Our multifaceted approach addresses pressing social issues in Japan, such as an aging population and the resulting shortage of healthcare professionals, as well as the expanding burden of national healthcare costs. Through our services, we aim to alleviate patients' concerns and improve their healthcare experience. We will continue developing socially responsible projects under the philosophy of connecting people with healthcare for a healthier society.